Hims & Hers Health, Inc. (HIMS)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 149 | 272 | 527 | 872 | 1,477 | 2,348 | 2,578 | 3,206 |
| Operating profit | $m | 106 | -93 | ||||||
| Net profit | $m | -18 | -108 | -66 | -24 | 126 | 128 | -142 | -160 |
| EPS reported | $ | 0.51 | -0.63 | ||||||
| Operating cashflow per share | $ | 1.33 | 1.15 | ||||||
| Capex per share | $ | 1.00 | 0.76 | ||||||
| FCF per share | $ | 0.33 | 0.39 | ||||||
| Free cash flow | $m | 74 | 90 | ||||||
| Net debt | $m | 395 | 524 | ||||||
| Book value equity | $m | 541 | 324 | ||||||
| Book value per share | $ | 2.09 | 1.40 | ||||||
| Number of shares | m | 258.23 | 231.75 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 63.67 | - | ||||||
| P/B LTM | x | 13.50 | 22.54 | ||||||
| P/S LTM | x | 3.11 | 2.83 | ||||||
| P/FCF LTM | x | 98.76 | 81.26 | ||||||
| EV/EBITDA LTM | x | 45.94 | -107.26 | ||||||
| EV/Sales LTM | x | 3.49 | 2.80 | ||||||
| Earnings Yield LTM | % | +1.57% | -2.18% | ||||||
| FCF Yield | % | +1.01% | +1.23% | ||||||
| Quality | |||||||||
| ROE | % | +23.73% | -30.03% | ||||||
| ROIC | % | +6.02% | -3.73% | ||||||
| Operating margin | % | +4.50% | -3.59% | ||||||
| Gross margin | % | +73.84% | +64.68% | ||||||
| FCF/Sales | % | +3.15% | +3.49% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -3.77% | - | ||||||
| Sales Growth YoY | % | +59.00% | +74.61% | ||||||
| Net Income Growth YoY | % | +1.85% | - | ||||||
| FCF Growth | % | -62.71% | -54.68% | ||||||
| Operating Profit Growth | % | +70.61% | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.07 | 0.06 | ||||||
| Net Debt/EBITDA | x | 5.00 | -12.25 | ||||||
| EBIT/Net interest | x | 0.00 | 0.00 | ||||||
| Net debt/market cap | % | +13.31% | +21.93% | ||||||
| Net debt/Equity | x | 0.73 | 1.62 | ||||||
| Gross debt/equity | x | 2.07 | 4.77 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free